chr6-32041097-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000500.9(CYP21A2):c.1451G>A(p.Arg484Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000133 in 150,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R484?) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000500.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP21A2 | NM_000500.9 | c.1451G>A | p.Arg484Gln | missense_variant | 10/10 | ENST00000644719.2 | |
CYP21A2 | NM_001128590.4 | c.1361G>A | p.Arg454Gln | missense_variant | 9/9 | ||
CYP21A2 | NM_001368143.2 | c.1046G>A | p.Arg349Gln | missense_variant | 10/10 | ||
CYP21A2 | NM_001368144.2 | c.1046G>A | p.Arg349Gln | missense_variant | 9/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP21A2 | ENST00000644719.2 | c.1451G>A | p.Arg484Gln | missense_variant | 10/10 | NM_000500.9 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150796Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000880 AC: 2AN: 227246Hom.: 0 AF XY: 0.0000161 AC XY: 2AN XY: 124498
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000419 AC: 6AN: 1432468Hom.: 0 Cov.: 33 AF XY: 0.00000561 AC XY: 4AN XY: 712730
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150796Hom.: 0 Cov.: 33 AF XY: 0.0000136 AC XY: 1AN XY: 73570
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 25, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Aug 25, 2015 | The CYP21A2 c.1451G>A (p.Arg484Gln) variant (also known as R484Q and R483Q) has been reported in the published literature in several individuals affected with 21 hydroxylase deficiency (PMIDs: 33864926 (2021), 30048636 (2018), 24667412 (2014), 24790362 (2008)) with either a simple virilizing (PMIDs: 32289882 (2020), 17119906 (2007)) or a nonclassic (PMIDs: 30968594 (2019), 19208730 (2009), 12915679 (2003)) phenotype. Functional studies show the variant has severely reduced activity, 1.1-1.89% activity for17-OHP and 2-3.8% activity for progesterone, compared to the wild-type (PMIDs: 24790362 (2008), 17119906 (2007)). The frequency of this variant in the general population, 0.0000088 (2/227246 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Based on the available information, this variant is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at